Literature DB >> 6336217

Dynamic SPECT with Xe-133: regional cerebral blood flow in patients with unilateral cerebrovascular disease: concise communication.

U Buell, E A Moser, P Schmiedek, G Leinsinger, T Kreisig, C M Kirsch, K Einhäupl.   

Abstract

To validate xenon-133 dynamic single photon emission tomography (SPECT) clinically, 74 patients were examined. Strictly unilateral cerebrovascular disease was confirmed in 47 patients by clinical history and by transmission computerized tomography (TCT) and contrast angiography. Twenty-seven were excluded, considered normal. SPECT flow maps were evaluated visually (against TCT) or by automated region of interest (ROI) techniques (12 areas per slice) to measure area flow (AF) (ml/100 g-min) and interhemispherical area flow ratios (AR). These were compared with normal values. Minimum AF in affected hemisphere decreased, and AR-to-normal difference increased, with the severity of the disease. Visually, low-flow areas were detected twice as frequently in SPECT as areas of low density of TCT. In reversible episodes, sensitivity of AF alone ws significantly below the sensitivity of combined evaluation of flow and ratio.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6336217

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  4 in total

1.  Semiquantitative analyses of dynamic single photon emission computed tomography (SPECT) of the primary auditory cortex.

Authors:  A Schadel; M Fischer
Journal:  Arch Otorhinolaryngol       Date:  1989

2.  Measurement of regional cerebral blood flow and accentuation of the primary auditory cortex with single photon emission computed tomography.

Authors:  A Schadel; M Fischer
Journal:  Arch Otorhinolaryngol       Date:  1989

3.  A study of acetazolamide-induced changes in cerebral blood flow using 99mTc HMPAO SPECT in patients with cerebrovascular disease.

Authors:  S Asenbaum; A Reinprecht; T Brücke; S Wenger; I Podreka; L Deecke
Journal:  Neuroradiology       Date:  1995-01       Impact factor: 2.804

4.  Cerebral and cerebellar uptake of 99mTc-(d,1)-hexamethyl-propyleneamine oxime (HM-PAO) in patients with brain tumor studied by single photon emission computerized tomography.

Authors:  M W Lindegaard; A Skretting; B Hager; K Watne; K F Lindegaard
Journal:  Eur J Nucl Med       Date:  1986
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.